🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Several experts said the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Service Response and Material Removal

Based on TikTok, the platform has removed violative material and prohibited associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.

Within moments of entering one community, a vendor posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Pricing

Within these groups, messages show black plastic packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service said it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to potentially significant medical dangers”.